The Consortium for Clinical Research and Innovation, Singapore (CRIS) is a national organization established in 2020 under MOH Holdings. It aims to enhance collaboration among key health research and development initiatives in Singapore, promoting innovation in clinical research and translation within the healthcare system. CRIS brings together six national R&D initiatives, including the Singapore Clinical Research Institute and the National Health Innovation Centre Singapore, to align efforts with the needs of patients, researchers, and the healthcare industry. Led by CEO Dr. Danny Soon, CRIS supports Singapore's "Healthier SG" strategy by advancing preventive care, precision medicine, and efficient clinical trial environments. The organization focuses on building networks for clinical trials, performing cost-effectiveness assessments, and fostering partnerships to ensure sustainability and relevance in health-tech and clinical research.